Sernova Biotherapeutics (TSX:SVA) EPS (Basic) : C$-0.08 (TTM As of Jan. 2025)

View and export this data going back to 1998. Start your Free Trial

What is Sernova Biotherapeutics EPS (Basic)?

Sernova Biotherapeutics's basic earnings per share (Basic EPS) for the three months ended in Jan. 2025 was C$-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2025 was C$-0.08.

Sernova Biotherapeutics's EPS (Diluted) for the three months ended in Jan. 2025 was C$-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2025 was C$-0.08.

Sernova Biotherapeutics's EPS without NRI for the three months ended in Jan. 2025 was C$-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2025 was -0.08.

During the past 3 years, the average EPS without NRI Growth Rate was -48.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -47.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was -21.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Sernova Biotherapeutics's highest 3-Year average EPS without NRI Growth Rate was 48.90% per year. The lowest was -111.80% per year. And the median was -14.50% per year.

Sernova Biotherapeutics EPS (Basic) Historical Data

The historical data trend for Sernova Biotherapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics EPS (Basic) Chart

Sernova Biotherapeutics Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

EPS (Basic)

Get a 7-Day Free Trial

-0.03

-0.09

-0.13

-0.10

Sernova Biotherapeutics Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
EPS (Basic)	Get a 7-Day Free Trial															-0.03	-0.03	-0.02	-0.01	-0.02

Sernova Biotherapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sernova Biotherapeutics's Basic EPS for the fiscal year that ended in Oct. 2024 is calculated as

Basic EPS (A: Oct. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-32.192	-	0)	/	306.954
	=	-0.10

Sernova Biotherapeutics's Basic EPS for the quarter that ended in Jan. 2025 is calculated as

Basic EPS (Q: Jan. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-5.695	-	0)	/	327.475
	=	-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.08

Sernova Biotherapeutics (TSX:SVA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sernova Biotherapeutics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (TSX:SVA) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH0:Germany PSH0:Germany PSH0:Germany

Address

700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Executives